Related Experiment Video
Updated: Jun 26, 2026
An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
Published on: September 12, 2019
Monitoring of hepatocellular carcinoma
1Department of Gastroenterology, University Hospital of Hached, University of Sousse, Faculty of Medicine of Sousse, Sousse 4000, Tunisia. imenakkaribm@gmail.com.
Screening for hepatocellular carcinoma (HCC) is crucial for at-risk patients. However, following international monitoring guidelines is challenging, necessitating improved screening strategies and patient selection.
Area of Science:
- Hepatology
- Oncology
- Public Health
Background:
- Hepatocellular carcinoma (HCC) screening is evidence-based for high-risk individuals.
- Adherence to current international monitoring guidelines for HCC surveillance presents significant challenges.
Purpose of the Study:
- To highlight the difficulties in adhering to recommended HCC monitoring protocols.
- To emphasize the need for optimizing screening options and patient risk stratification for HCC.
Main Methods:
- This study is a review of current evidence-based approaches for HCC screening.
- Analysis of adherence challenges and identification of areas for improvement in patient selection.
Main Results:
- Current HCC screening protocols face practical adherence issues.
- There is a clear need for more effective and accessible screening methods.
Conclusions:
- Improving adherence to HCC screening requires refining current strategies.
- Future efforts should focus on enhancing patient selection and optimizing screening modalities to improve outcomes for hepatocellular carcinoma.
Related Concept Videos
01:28Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test